Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Scotland votes no for independence

September 19, 2014 Medical Communications, Research and Development, Sales and Marketing NHS, Scotland

The United Kingdom remains united today as Scotland  narrowly voted against breaking up the 307-year-old union. The ‘No, Better Together’ …
News
christy_nolandweb

Astellas appoints comms head from Baxter

September 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris

Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …
Appointment
eric_hansen

New managing director for PAN

September 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Jon Linscott, Pan, eric hansen

Creative comms agency PAN has appointed a new managing director in Eric Hansen who replaces the recently-departed Jon Linscott.Reporting in …
Appointment

Cancer drug gains first early UK access grant

September 17, 2014 Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising

A new type of cell therapy for cancer has become the first to be deemed by the UK government as …
News
screen_shot_2014-09-17_at_07

Epic Sciences hires regulatory affairs VP

September 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing epic sciences, paul frieberg

San Diego-based cancer diagnostics firm Epic Sciences has appointed Glen Paul Freiberg as its vice president of regulatory affairs and …
Appointment
Pfizer image

Pfizer partners with MedGenesis on Parkinson’s

September 16, 2014 Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience

Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …
News
AZ image

AstraZeneca teams up with rival Lilly for Alzheimer’s

September 16, 2014 Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly

AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …
News

No silver bullet, but a growing arsenal for pharma comms

September 16, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck, comms, eyeforpharma, mcm, selincro, tim white

Digital strategies in the pharma industry have predominately been a red herring, focussing too much on the novelty of digital …
Feature
professor_roberto_pellicciari

Tiziana appoints Intercept head to its board

September 16, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roberto pelliccaiari, tiziana

UK biotech firm Tiziana Life Sciences has confirmed that Professor Roberto Pellicciari is joining its scientific advisory board and will …
Appointment
ceneris

Cerenis announces board chairman

September 12, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerenis

France and US-based biopharma firm Cerenis Therapeutics has confirmed the appointment of Dr Richard Pasternak as its chairman of the …
Appointment
peter_impey_10ten

90TEN Healthcare appoints comms director

September 11, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Lottie Tupholme, Peter Impey, Steve Ramsey

London comms agency 90TEN Healthcare has hired Peter Impey as its director of international communications, and added two heads to …
Appointment

NICE seeks more trial data from pharma

September 10, 2014 Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency

NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …
News
ERS event image

InterMune’s IPF drug shines at ERS Congress

September 10, 2014 Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, IPF, InterMune, idiopathic pulmonary fibrosis, munich, pirfenidone

InterMune has posted positive data for its lung-scarring drug at this year’s European Respiratory Society Annual Congress 2014 (ERS). Pharmafile …
News
Apple image

Apple launches health-centred smartwatch

September 10, 2014 Medical Communications, Research and Development, Sales and Marketing Android, Apple, Jobs, Samsung, apple watch, google, health kit

Apple has finally unveiled its long-rumoured ‘smartwatch’ to the world along with new iPhones and a payment system. At the …
News
Evotec image

Trial misconduct halts Evotec/Hyperion drug

September 10, 2014 Research and Development, Sales and Marketing DiaPep277, Evotec, amdromeda, diabetes, hyperion

Development of Evotec and Hyperion Therapeutic’s diabetes drug DiaPep277 has been terminated following ‘serious misconduct’ in one of its trials. …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026